Search
for
Sort by
Research 451–480 of 1000+
- Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- Finasteride Treatment of Hair Loss in Women
- The efficacy and use of finasteride in women: a systematic review
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study
- Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- Finasteride for recurrent priapism in children and adolescents: a report on 5 cases
- Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
- Finasteride in the Treatment of Hirsutism
- Encapsulation of finasteride with native and modified γ-cyclodextrins. Extensive characterization of the complexes
- Untargeted Metabolomics and Steroid Signatures in Urine of Male Pattern Baldness Patients after Finasteride Treatment for a Year
- Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia
- Increasing utility of finasteride for frontal fibrosing alopecia
- Analyzing finasteride data
- Controlled clinical trial for evaluation of hair growth with low dose cyclical nutrition therapy in men and women without the use of finasteride
- Efficacy and safety of topical combination of 3% minoxidil and 0.25% finasteride versus 3% minoxidil solution in female-pattern hair loss: A randomized, double-blind, controlled study
- A cross-sectional randomized comparative study of topical minoxidil solution with and without finasteride in male pattern androgenetic alopecia in South Indian patients
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Topical Finasteride Therapy in Hirsutism
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Finasteride-Induced Neuropsychiatric Reactions
- The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
- The Efficacy of Oral Finasteride and Dutasteride in the Treatment of Female Pattern Hair Loss and Frontal Fibrosing Alopecia in Women: A Scoping Review
- Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- A finasteride patch for the treatment of androgenetic alopecia: A study of promoting permeability strategy using synthetic novel O-acylmenthols combined with ion-pair